Colorectal cancer (CRC) represents one of the most commonly diagnosed cancers worldwide.
It is the second leading cause of cancer death in Western Countries. In the last decade …

Lenvatinib is an emerging multi-kinase inhibitor with a preferential anti-angiogenic activity,
which has shown efficacy in the treatment of renal cell carcinoma, differentiated thyroid …

Background: Prognosis of advanced pancreatic cancer is dismal and the novel targeted
therapies, albeit successfully used to treat many advanced tumors, have shown modest results. …

RESULTS Of our patients, 48.9% said they use or have recently used CAM. The univariate
analysis showed that female gender, high education, receiving treatment in a highly …

Cetuximab is a monoclonal antibody to the EGFR that induces antibody-dependent cell
cytotoxicity (ADCC) through Fcγ receptors on immune cells. Although SNPs in genes encoding …

… (not found in the present study) [16], a decreased amplitude of sensory nerve action
potentials at mid-… A more recent study showed that patients with diabetes developed OXA-induced …

Background & Aims Metformin seems to have anticancer effects. However, it is not clear
whether use of glycemia and metformin affect outcomes of patients with advanced pancreatic …

Objective: The aim of this study was to evaluate clinical and morphological features related
to nodal involvement in appendiceal neuroendocrine tumors (NETs), to identify patients who …

Electrochemotherapy is a local non-thermal treatment for cancer ablation. Currently, many
studies and case report have investigated the differences in effectiveness of …

Purpose To evaluate the antiproliferative activity and safety of nonconventional high doses of
somatostatin analogs (HD-SSA) in patients with well-differentiated gastroenteropancreatic (…